𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of Certolizumab Pegol for Crohn’s Disease: A Systematic Review and Meta-Analysis

✍ Scribed by Wei Da, Jinshui Zhu, Long Wang, Yunmin Lu

Book ID
120960416
Publisher
Springer Healthcare Communications
Year
2013
Tongue
English
Weight
494 KB
Volume
30
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of certolizumab pego
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
✍ Alain M. Schoepfer; Stephan R. Vavricka; Janek Binek; Christian Felley; Martin G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Background: Switzerland was the first country to approve certolizumab pegol (Cimzia, CZP) for the treatment of patients with moderate to severe Crohn's disease (CD) in September 2007. This phase IV study aimed to evaluate the efficacy and safety of CZP in a Swiss multicenter cohort of practice-based